insights_auto
Why is CUV down 2.11%?
Dive Deeperchevron_right
CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$7.43
arrow_downward
-2.11%(-0.16) 1D
Nov 17, 1:58:27 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$7.46
High
A$7.51
Low
A$7.36
Mkt. cap
375.12M
Avg. vol.
158.10K
Volume
48.52K
Dividend
0.67%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
11.12
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
Open
A$7.46
High
A$7.51
Low
A$7.36
Mkt. cap
375.12M
Avg. vol.
158.10K
Volume
48.52K
Dividend
0.67%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
11.12
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
News stories
From web sources and news partners
marketscreener.com
·
5 hours ago
Nasdaq, S&P 500 Fall For Third Day as Nvidia Sell-Off Continues
BigGo Finance
·
13 hours ago
Bitget Opens Onchain Yield Vaults for Tokenized S&P 500, Nasdaq-100 Trackers
ChartMill
·
9 hours ago
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
www.tokenpost.com
·
43 minutes ago
Defensive S&P 500 Sectors Outpace Nasdaq 100 by 26 Percentage Points
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteclinuvel.com